Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
CALAVI will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.
Epistemonikos ID: 26f4981e9ece24c2040c42ec7164dfbb1d505e75
First added on: Apr 16, 2020